You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 2, 2025

Drug Price Trends for NDC 61314-0547


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 61314-0547

Drug NameNDCPrice/Unit ($)UnitDate
LATANOPROST 0.005% EYE DROPS 61314-0547-03 1.22991 ML 2025-03-19
LATANOPROST 0.005% EYE DROPS 61314-0547-01 1.86544 ML 2025-03-19
LATANOPROST 0.005% EYE DROPS 61314-0547-03 1.24384 ML 2025-02-19
LATANOPROST 0.005% EYE DROPS 61314-0547-01 1.79597 ML 2025-02-19
LATANOPROST 0.005% EYE DROPS 61314-0547-03 1.30787 ML 2025-01-22
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 5 of 5 entries

Best Wholesale Price for NDC 61314-0547

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
No data available in table
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 0 to 0 of 0 entries

Market Analysis and Price Projections for NDC 61314-0547

Understanding the NDC Code

The National Drug Code (NDC) is a unique, three-segment number that serves as the FDA’s identifier for drugs. For the NDC 61314-0547, this code identifies the labeler, the specific product, and the trade package size. Here’s a breakdown of what each segment represents:

  • Labeler Code: The first segment (61314) is assigned by the FDA and identifies the firm that manufactures, repacks, or relabels the drug.
  • Product Code: The second segment identifies a specific strength, dosage form, and formulation for the particular firm.
  • Package Code: The third segment identifies the package sizes and types[5].

Drug Identification

To analyze the market and price projections for NDC 61314-0547, it is crucial to identify the drug associated with this code. However, the specific drug name and details are not provided in the sources. Typically, you would refer to the FDA's National Drug Code Directory or other pharmaceutical databases to find this information.

Market Trends in the Pharmaceutical Industry

Pricing and Access

The pharmaceutical industry, particularly in the U.S., is facing significant challenges related to drug pricing and access. According to Deloitte's 2025 life sciences outlook, pricing and access to drugs are among the most significant issues facing the industry. Nearly half of the surveyed executives expect these factors to significantly impact their strategies in 2025[3].

Competition from Generics and Biosimilars

Competition from generic drugs and biosimilars is another key trend. 37% of respondents in Deloitte's survey view this as a top trend, with the biopharma industry facing a substantial loss of exclusivity due to expiring patents on high-revenue products. This could influence the pricing and market dynamics of branded drugs[3].

Global Price Comparisons

The U.S. market is characterized by higher drug prices compared to other regions. The average price per unit in the U.S. is 5.5 times higher than in the OECD (excluding the U.S.) and 7.7 times higher than in the rest of the world. This disparity is partly due to the drug mix in the U.S., which skews towards more expensive compounds[4].

Price Projections

Historical Pricing Data

For accurate price projections, historical pricing data is essential. While specific data for NDC 61314-0547 is not available in the provided sources, general trends can be inferred. For example, the average price per unit for all drugs in the U.S. increased by 14% between 2017 and 2022, whereas prices in other regions decreased[4].

Market Analysis

To project prices for a specific drug, one would typically analyze:

  • Current Market Prices: Look at recent pricing data for the drug to understand its current market value.
  • Competitor Pricing: Analyze prices of similar drugs or generics/biosimilars that could impact the market.
  • Regulatory Changes: Consider any upcoming regulatory changes that might affect pricing, such as changes in reimbursement policies or patent expirations.
  • Demand and Supply: Evaluate the demand for the drug and any changes in supply that could influence pricing.

Example Analysis for Similar Drugs

For instance, looking at the pricing data for another drug like CLIMARA 0.06 MG/DAY PATCH (NDC 50419-0459), we see that prices have remained relatively stable over recent months, with minor fluctuations. This stability could be due to consistent demand and supply, as well as the absence of significant competitive or regulatory changes[2].

Key Considerations for Price Projections

  • Patent Expirations: If the drug associated with NDC 61314-0547 is nearing patent expiration, this could lead to increased competition from generics or biosimilars, potentially reducing prices.
  • Regulatory Environment: Changes in FDA regulations or reimbursement policies can significantly impact drug prices.
  • Technological Advancements: Innovations in drug delivery or formulation could affect pricing by either increasing or decreasing production costs.
  • Global Market Trends: The drug's performance in other markets can influence its pricing in the U.S.

Conclusion

Without specific data on the drug associated with NDC 61314-0547, precise price projections are challenging. However, understanding the broader market trends, regulatory environment, and competitive landscape can provide valuable insights into potential price movements.

Key Takeaways

  • NDC Code: The NDC code is a unique identifier for drugs, consisting of three segments that identify the labeler, product, and package size.
  • Market Trends: The pharmaceutical industry is influenced by pricing and access issues, competition from generics and biosimilars, and global price disparities.
  • Price Projections: Historical pricing data, competitor pricing, regulatory changes, and demand-supply dynamics are crucial for accurate price projections.
  • Regulatory Environment: Changes in FDA regulations and reimbursement policies can significantly impact drug prices.

FAQs

Q: What does the NDC code represent? A: The NDC code is a unique, three-segment number that identifies the labeler, the specific product, and the trade package size of a drug.

Q: Why are drug prices higher in the U.S. compared to other regions? A: Drug prices in the U.S. are higher due to a combination of factors including higher prices for the same drugs and a drug mix that skews towards more expensive compounds.

Q: How do patent expirations affect drug prices? A: Patent expirations can lead to increased competition from generics or biosimilars, potentially reducing prices.

Q: What role does the FDA play in drug pricing? A: The FDA does not directly set drug prices but regulates the approval and listing of drugs, which can indirectly influence pricing through regulatory changes and approval processes.

Q: How can technological advancements impact drug prices? A: Technological advancements can affect pricing by either increasing or decreasing production costs, depending on the innovation.

Sources

  1. FDA's National Drug Code Directory - FDA
  2. Latest drug prices and trends for NDC 50419-0459 - DrugPatentWatch
  3. 2025 life sciences outlook - Deloitte Insights
  4. International Market Size and Prices - ASPE
  5. National Drug Code Database Background Information - FDA

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.